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Vievvpoint

A Nevv Phase of Development
The opening of the John D. Rockefeller, Jr. and David Rockefeller Research
Building marks a new phase in the development of this university and cam
pus. The 100,000 square feet of new laboratory space inside this $90 million
dollar, state-of-the-art building will enable us to recrult new junior and
senior faculty, and free up facilities for scientists working on other parts of
the campus who for years have needed additional research space.
To celebrate the opening of this marvelous new facility, we invited repre
sentatives from many worlds-govern�ent, business, science, and culture.
For this day of dedication and the three festive days that followed it, we tried
to take as much of the ivory out of our tower as possible. We organized
exhibits, tours, and lectures for friends of The Rockefeller University, for the
surrounding community, and for individuals in all parts of this university, to
demonstrate our desire to be linked more closely with the diverse worlds of
this great city.
For all the astounding intellectual and technical advances of recent years, the scientists of this campus's
past would find much that is familiar in the laboratories this building will house-labs devoted to cell biology
and immunology, to molecular and structural biology-all fields that the university helped pioneer. And
I am certain that they also would find familiar the continuing commitment of the Rockefeller family to this
university. But they might be surprised by another name that helped make this building possible-that of
Howard Hughes. The Howard Hughes Medical Institute has quite literally provided the foundation for our
new facility, and will continue to support the Howard Hughes senior and junior investigators working on
four of its floors.
The similarity between the Howard Hughes Medical Institute and The Rockefeller University transcends
the parallel use of private fortunes for the public good. Both share a philosophy that strikes at the heart of the
whole scientific enterprise: Find the most talented researchers possible, and then give them the facilities and the
freedom to pursue their studies wherever they might lead. For like novelists being surprised when one of their
characters takes on a life of its own-performing actions that were not planned, not part of the plot-we scien
tists are constantly being overtaken by surprises as we work in our laboratories. We try to make a cell do one
thing, and instead it keeps doing another, until we are forced to ask: Why is it doing that? And then, this new
question asked, we are off performing a series of experiments we could hardly have anticipated a week ago.
The current debate in Washington on how best to balance support for basic and applied research is in some
ways misleading: the two interpenetrate. The history of science at Rockefeller and other research institutions
powerfully attests that it is the asking of basic questions about the operations of nature, pursued by investigators
working alone or in small groups, that largely provides the foundations for novel clinical and industrial applica
tions. Science is a creative activity rooted in the independence of the individual researcher, and respect for this
intellectual freedom must continue to be at the core of government support for science.
Yet in times of scarce resources, we in the scientific community recognize that more must be done to enable
the fruits of our discoveries to blossom into economically and medically useful technologies and treatments.
Whether our t9wers are made of ivory, or of glass, steel, and stone, they must have doors that lead out as well
as in. Let us hope they lead out to more open-air symposia like the one that occurred at the opening of our new
research facility, when the worlds of government, business, science and culture came together and freely dis
cussed how our common interests may best be served.

Torsten Wiesel
President. The Rockefeller University

The Shape of Nature

X-ray crystallography and nuclear magnetic resonance
spectroscopy reveal the 3-D structure of molecules
by Susan Blum
In the course of its lifetime, a cell
receives countless messages to grow,
divide, .ind differentiate. Properly
communicated, these messages pro
mote the normal development and
healthy functioning of the organism
to which the cell beAmong biology's
longs. But if the commu
nication goes awry, dis
most compelling (and
aster can ensue.
competitive) efforts
Among biology's most
compelling
(and com
is the search to
petitive) efforts is the
unravel the intricasearch to unravel the
intricacies
of the cellular
cies of the cellular
signaling network. Re
signaling netvvork.
cently, two Rockefeller
research
groups ad
Recently, tvvo
vanced this endeavor sig
Rockefeller research
nificantly by providing
important
new informa
groups advanced
tion about a crucial ele
this endeavor signifi
ment in the signaling
matrix. Each group start
cantly by providing
ed work independently,
important nevv
using their own special
ized research techniques.
information about a
But their efforts were
crucial element in the
facilit ated by Rocke
feller's historic areas of
signaling matrix.
scientific inquiry, and by
the unique opportunities for com
munication that the university's
structure provides.
In a hotly contested field, the
Rockefeller researchers provided the
first views of the three-dimensional
structure of protein regions called
SH2 domains. A protein "domain"
is a protein segment that performs a
particular function. An individual
protein may contain many different
domains with different functions.
The role of SH2 domains, found in
a large number of proteins, is to
serve as "readers" for messages sent
through the cell in response to sig
nals that reach its surface.
Susan Blum is a science writer in The

Rockefeller University Public Affairs Office.
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"To send a signal, you need
something that acts as a switch, like
a green or red light," explains John
Kuriyan, who led one of the multi
lab groups involved in the research.
There are several kinds of molecular
switches, one of the most important
of which is a phenomenon known as
tyrosine phosphorylation. This is a
process that p�ts a highly charged
substance called phosphate on tyro
sine, one of the twenty amino acids
used as the building blocks for all
proteins. The specific pattern of
tyrosine phosphorylation varies for
each different protein that can serve
as a molecular switch.
TRIPPING THE
MOLECULAR SWITCH

SH2 domains bind to phosphorylat
ed tyrosines, thereby registering that
the molecular s witch has been
tripped. The protein in which the
SH2 domain is embedded then
helps pass the cellular signal along.
"SH2 domains are vitally important
in regulating cell differentiation,
growth, and division," says David
Cowburn, the leader of the other
multi-lab team. "The aberrant cell
differentiation that leads to birth
defects and the uncontrolled cell
growth that is a hallmark of cancer
frequently result from the break
down of switching mechanisms
directly involved with these
domains." Indeed, many oncogenes,
or cancer genes, are genes whose
normal function is to c�de for pro
teins containing SH2 domains.
When these genes are mutated, the
messages they transmit are scram
bled in ways that can contribute
to cancer.
Be fore the work of the two
Rockefeller groups was published
simultaneously last summer, scien-

tists had already determined the
order in which the amino acids of
SH2 domains are linked together
like beads on a chain. But this
knowledge, though useful, gave no
hint about how the domains actually
accomplish their cellular tasks. To
know how any protein functions,
researchers must also know its 3-D
structure-the characteristic confor
mation of twists, pockets, and pro
jections that endows it with exactly
the right combination of chemical,
mechanical, and electrostatic forces
to get the job done. Thus, by pro
viding the first 3-D views of two dif
ferent SH2 domains, the Rockefeller
researchers inaugurated a new phase
in the understanding of the cellular
signaling network. (A third group,
from Oxford a11d London Univer
si ties, reported the structure of
another SH2 domain at the same
time.)
The team headed by Cowburn
revealed the structure of the SH2
domain of a protein called abl (pro
nounced "able.") The gene that
codes for this protein-a gene that
is involved in leukemia-is under
intensive study in the laboratory
of Rockefeller Professor David
Baltimore. Researchers in the
Baltimore lab collaborated with the
Cowburn group by supplying ample
quantities of the abl protein's SH2
domain.
The domai? was the right size
for investigation by the nuclear
magnetic resonance (NMR) spec
troscopy tech�iques. employed by
members of the Cowburn lab. This
method, which studies molecules as
they float in solution, exploits the
magnetic properties 6f atomic
nuclei, revealing the distances
between atoms and the "cross talk"
they engage in (s ee "How does

nuclear magnetic resonance spec
troscopy work?", page 14).
The group led by Kuriyan
derived the structure of the SH2
domain of a protein called src (pro
nounced "sark"). The gene that
codes for this protein has a long tra
dition of study at Rockefeller dating
back to 1911, when Peyton Rous
isolated a virus that transmitted
cancer among chickens. The virus'
cancer-causing gene was later iden
tified and named src. As one of the
first cancer genes ever investigated,
src is in many ways a reference point
for researchers; in fact, the "SH" in
the name SH2 stands for "src
homology region."
Today, the src gene is under
intensive study in the laboratory of
Rockefeller professor Hidesaburo
Hanafusa, as well as in the laborato
ry of Marilyn R�sh, a cancer
researcher at Sloan-Kettering
Institute for Cancer Research (see
"Cracking Cancer's Secret Code,"
page 16). Together, these two scien
tists provided the guidance and
insights that enabled researchers in
the Kuriyan lab to use the tech
niques of molecular biology to pro
duce the large quantities of the src
SH2 domain they needed for their
studies.
The Kuriyan lab used the tech
niques of x-ray crystallography to
derive their 3-D structure. This
method bombards crystallized pro
teins with x-ray beams. The beams
bounce off electrons whirling
around individual atoms within the
crystal, and then scatter ("diffract")
in all directions. The pattern of this
diffraction can be interpreted to
reveal the 3-D structure (see "\Vb.at
is x-ray crystallography?", page 12).
The Kuriyan and Cowburn labs
embarked on their projects indepen
dently, but they soon learned about
one another's research. "Rockefeller
has a very high c.oncentration of labs
working on biological problems
without departmental barriers. You
tend to talk to a lot of people,"

first-ever view of any bound tyro
sine-phosphorylated peptide.)
"Comparing these two structures
allows us to see the SH2 domain in
both its 'on' and 'off' states,"
Kuriyan points out. The double
view presents unparalleled insights
into how this crucial linker protein
may bind to cellular switches and
pass the signal along .. Ultimately,
such insights may lead to a better
understan4ing of how cancer devel
ops, and to therapies that might halt
its progress. With a detailed knowl
edge of how SH2 domains bind to
tyrosine-phosphorylated proteins, it
might be possible to build small
molecular inhibitors that block these
interactions. Such "rational drug
REVEALING THE
design" is still years away, but is a
FORCES THAT BIND
distinct possibility thanks to the
The structures revealed by the
kind of structural information pro
research groups show that the SH2
vided by NMR and x-ray crystallo
domains have a novel socket-like
graphic techniques.
area that binds the region of the
The structures of the src and abl
switch protein containing phospho
SH2 domain are so similar that the
rylated tyrosine. By revealing this
Rockefeller researchers believe all
area of the SH2 domain on an atom
SH2 domains will prove to resemble
by-atom basis, the structures give
each other overall. But now a new
powerful insights into the various
question beckons. Though all SH2
forces that contribute to the bind
domains probably bind just about all
ing. The structures also show that,
proteins containing phosphorylated
as a whole, the SH2 domain has a
tyrosine, each domain has its own
modular aspect, thus explaining how
characteristic pattern, binding some
SH2 domains can
tyrosine-phos
be a part of so In a hotly contested field,
phorylated
many different
proteins very
kinds of proteins the Rockefeller researchers
strongly, and
(see illustrations, provided the first vievvs of
others only
page 6).
weakly. What
Though the the three-dimensional strucstructural feawork of both ture of protein regions called
tu res
make
res,e arch groups
each SH2 do
resulted in views of SH2 domains.
main different
the 3-D structures
from all the
of SH2 domains, their investigations
others? Once researchers such as
differed in one important way. The
Kuriyan and Cowburn can answer
NMR studies presented a view of
these questions, they will be closer
the domain in its unbound state,
still to a fundamental understanding
while the x-ray crystallography stud
of how cellular messages are com
ies visualized it bound to a tyrosine
municated, and of how they might
phosphorylated peptide. (Not only
be intercepted when they threaten
was this a first for studies of SH2
to go awry.
domains, but it also provided the

Kuriyan says.
Scientists in the Cowburn lab
had synthesized small tyrosine
phosphorylated protein segments
(called peptides) as part of a series of
studies; but, for technical reasons,
NMR could not visualize these pep
tides bound to the abl SH2 domain.
The Cowburn lab provided the pep
tides to the Kuriyan lab. \Vb.en they
were 'mi xed with the src SH2
domains, crystals resulted that were
close to ideal for the x-ray crystallo
graphic studies. The Cowburn
group also provided the Kuriyan lab
with some data on the abl SH2
domain derived from their NMR
studies.

..... .
5

� TWO DIFFERENT
SH2 DOMAINS HAVE
REMARKABLY
SIMILAR STRUCTURES

Research at Rockefeller using
nuclear magnetic resonance
(NMR) spectroscopy and X-ray
crystallography revealed remark
ably similar three-dimensional
structures for the SH2 domains
of two different proteins. They
show that the domains of both
proteins have a novel socket-like
area that can bind small protein
regions (peptides) containing
phosphoryla ted tyrosines-sub
stances that s'erve as an impor
tant "switch" to pass along cellu
lar messages. The NMR studies
provided a view of an SH2
domain in its unbound state
(top), while the x-ray crystallog
raphy studies visualized a
domain bound to a tyrosine
phosphorylated peptide, shown
in white (bottom). Comparing
these two structures allows the
researchers to see SH2 domains
in both their "on" and "off"
state-an important advance in
understanding the details of cel
lular communication. The struc
tures also show that, as a whole,
an SH2 domain has a modular
aspect. The two ends of the
domain are close to one another
and form simple strands that can
easily insert into any number of
proteins, while the bulk of the
protein takes the characteristic
twists, turns, and loops that are
essential to its function. This
modularity explains how SH2
domains can be a part of many
different kinds of proteins essen
tial for cellular communication.

6

DAVID COWBURN

Since the start of his research
career, Rockefeller faculty mem
ber David Cowburn has been
fascinated by the relationship
between the structure and func
tion of biological molecules.
Cowburn and his colleagues
were among the first to .realize
the potential of nuclear magnet
ic resonance (NMR) spec
troscopy to reveal a molecule's
three-dimensional structure. He
has been utilizing this method
for over a decade, all the while
making important contributions
to its improved sensitivity and
versatility.

David Cowburn joined The
Rockefeller University in 1973.
H e received his Ph.D . from
King's College at The Univer
sity of London in 1970. After a
postdoctoral fellowship at the
European Molecular Biology
Organization, he conducted
interdisciplinary research in
neurobiology and psychiatry at
Columbia University's College
of Physicians and Surgeons
before coming to Rockefeller.
In addition to his work on
the SH2 domain of the abl pro
tein, Cowburn and his col
leagues are cooperating with
researchers at Rockefeller and

elsewhere to explore the struc
ture of·other SH2 domains and
the tyrosine-phosphorylated
proteins to which they bind.
Another of his projects is an
investigation of the 3-D struc
ture of adenylate kinase, an
enzyme that catalyzes an essen
tial step in the conversion of
food to energy. Still other pro
jects using NMR seek to discov
er the structure of growth fac
tors and hormones, substances
that set the cellular communica
tion process in motion by bind
ing to receptors located at the
cell surface.
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The x-ray crystallographic stud
ies of Rockefeller faculty mem
ber John Kuriyan draw on a
combination of experimental
and theoretical approaches to
derive a molecule's 3-D struc
ture. They aim to understand, at
the level of atomic detail, how
proteins function as part of the
cellular machinery.
John Kuriyan joined The
Rockefeller University in 1987,
after receiving his Ph.D. from
the Massachusetts Institute of
Technology in 1986 and com
pleting a postdoctoral fellowship
at Harvard University. He was
named Assistant Investigator of
the Howard Hughes Medical
Institute in 1990.
In addition to the src SH2
domain and the protein region
to which it binds, a number of
other cellular "machines" are
currently under investigation in
his laboratory. One such protein
is a bacterial enzyme that is
required for the proper folding
of many proteins. Yet another
protein under study is DNA
polym erase III (Pol III), a com
plex bacterial enzyme involved
in chromosome replication, one
of life's most fundamental
processes. Kuriyan and his col
leagues have already discovered
the 3-D structure of Pol Ill's
"beta-subunit"-one of the ten
protein components that makes
up the bacterial enzyme. A long
term goal of the laboratory
members is to depict the struc
tures and explain the functions
of Pol Ill's nine other compo
nents. They are also pursuing
the structures of proteins that
perform similar functions in the
cells of plants and animals.

THE PROCESS OF
DISCOVERY: RUNNING
EXPERIMENTS AND
INTERPRETING RESUL5TS

Many scientists contributed to
the discovery of the 3-D struc
ture of the a bl SH2 domain.
(Clockwise from right) Postdoc
N alin Pant, postdoc Carlos Rios,
and graduate student Michael
Overduin are members of the
Cowburn lab. Overduin and
Rios were key players in running
the NMR experiments and
interp reting their results.
Overduin determined the
domain's final 3-D structure.
Pant synthesized short protein
fragments (peptides) for ongoing
studies in the Cowburn lab, and
also provided them . to re
searchers in the Kuriyan lab for
use in their studies of the src
SH2 domain. Rockefeller post
doc Bruce Mayer (not shown)
provided the Cowburn team
with ample qu antities of the
abl SH2 domain for their NMR
studies. Mayer is a member of
the laboratory of Rockefeller
f aculty member David Balti
more, where the cancer-causing
gene that codes for the abl pro
tein is under intensive study. �
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FINDING THE STRUCTURE:
MANY STEPS, MANY
SCIENTISTS INVOLVED

Numerous steps, and numerous
scientists, were involved in find
ing the 3-D structure of the src
SH2 domain bound to tyrosine
phosphoryla ted peptide. Rocke
feller scientist Hidesaburo
Hanafusa, a pioneer in studies of
the src gene, was among those
who provided guidance and
insight to postdoc Dorothea
Kominos (right) and research
associate Gabriel Waksman (left)
i n the Kuriyan lab. These
researchers, along with research
asssitant Scott Robertson (not
shown), used the techniques of
molecular biology to genetically
engineer as much of the src SH2
domain as they needed to grow
crystals of the protein. Waksman
conducted the x-ray crystallo
graphic studies, interpreted their
results, and derived the final 3-D
structure.�
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What is x-ray
crystallography?
X-ray crystallography reveals the three-dimensional
position of every atom in a molecule. The technique
has been used for simple molecules since 1912, but
the first protein structure was not achieved until 1959
after decades of effort. Recently, the pace of discovery
has accelerated remarkably thanks to powerful new
computing and recording equipment that speeds up
the process of data collection and analysis, and to
genetic engineering techniques that vastly increase
the number of proteins available for study.
In principle, x-ray crystallography is similar to,
natural vision or light microscopy: Electromagnetic
waves diffract off an object-in this case, the elec
trons whirling around atoms-and are then refocused
into an image. But crystallography uses x-rays rather
than visible light, because only x-rays have wave
lengths small enough to resolve the interatomic dis
tances within molecules. Moreover, since x-rays can
not be focused by any physical lens, crystallographers
use mathematics to "focus" the diffracted rays back
into an image.

A The electrons in a single
protein molecule would never
diffract x-rays well enough to
produce an image, but a crystal
of protein provides tens of tril
lions of molecules arrayed in a
lattice that diffracts x-rays
strongly. For reasons that
remain mysterious, growing
crystals is a chancy business.
Researchers can coax some
proteins to crystallize in less·
than a day, but must labor over
others for months or years.
Occasionally, despite their best
efforts, a satisfactory crystal can
never be grown.
Until recently, obtaining
sufficient supplies of protein
was also a problem for crystallo
graphers, since many of the
proteins they are most eager to
study are scarce in a cell. Today,
however, Rockefeller crystallog
raphers use recombinant DNA
technology to engineer and
mass-produce virtually any
protein they wish to study.

<II With the crystallized pro
tein obtained, researchers can
begin the process of data collec
tion. An x-ray source shoots a
beam of waves through the
crystal. To obtain all the neces
sary data, experiments are con
ducted so that the x-ray beam
hits the crystal at many different
angles. Most of the waves go
straight through the crystallized
protein, but some hit the elec
trons whirling around the atoms
and scatter, or diffract, in all
directions. Interference cancels
out some of the diffracted
x-rays, but reinforces others,
which are recorded on a detect
ing device.
At Rockefeller, many
experiments are conducted
using a state-of-the-art "area
detector," which registers many
diffracted x-ray beams at once
and sends the information
directly to a powerful mini-

.,.. The ensemble of diffracted
beams produces an array of spots·
called a diffraction pattern. To
learn more about the individual
atoms that generated this pattern,
three aspects of the diffracted
x-ray waves must be known: their
amplitude, their wavelength, and
their phase. The intensity of the
spots on the diffraction pattern
gives information about the
waves' amplitude, and the wave
lengths are known to the scien
tists from the start. But to solve
the so-called "phase problem,"
crystallographers must compare
the diffraction patterns made by
the original crystal with those
made by crystals of proteins to
which "marker" atoms have been
added. Such comparisons entail
growing new crystals, running
scores of additional diffraction
experiments, and performing
many complex mathematical cal
culations.
Once crystallographers have
solved the phase problem, they
can prompt computers to produce
a preliminary "electron density
map." The initial map, which
highlights regions of electron
density around each atom, is not
without errors. Nor does it
unequivocally tag each atom's
identity, since a number of atoms
resemble one another at the level
of detail the map can provide. The
task of refining and interpreting
the map is up to the crystallogra
phers. Drawing on their knowl
edge of chemistry, physics, and
mathematics, and referring to the
known amino-acid sequence of
the protein, atom by atom they
build up the structure of the pro
tein as a whole. .,..
When each atom in the electron
density map has been assigned its
identity, sophisticated computer
graphics can present the 3-D
structure in any number of for
mats. The protein's secondary
structure (its helices and strands),
the peaks and valleys of its sur
face, the chemical forces that
shape its internal dynamics, its
individual atoms-all can be dis
played in virtually any combina
tion. These beautiful images,
which can be moved and rotated
in all directions with the simple
click of a computer "mouse," help
crystallographers decipher the
innermost details of a protein's
structure, and thereby provide
insights into how the protein
___ :_L . t:. ..• _,: - ·-

Hovv does nuclear magnetic
resonance spectroscopy vvork?
Scientists have long used nuclear magnetic resonance (NMR) spectroscopy to
determine a molecule's chemical composition. But only in the past decade have
conceptual and technical advances made it possible to use NMR to determine the
3-D position of every atom in a molecule.
NMR exploits the fact that the nuclei of certain atoms-including hydrogen,
the most abundant atom in proteins-have an intrinsic spin that makes them act
like small bar magnets. Differences in the surrounding chemical "environment" of
each atom affect the behavior of these minuscule magnets in ways that give clues
to their position within the molecule. This information can then be used to de
velop a 3-D picture of the protein as a whole.
� NMR studies protein mole
cules as they float in solution, 'so
researchers who use this method
are freed from the challenges
x-ray crystallographers must sur
mount each time they attempt to
crystallize a protein. But NMR
poses its own constraints. The
proteins investigated with this
method must be highly soluble,
available in copious quantities,
and relatively small.
The NMR spectroscopists at
Rockefeller conduct the protein
chemistry necessary to obtain the
proteins and peptides they study.
They synthesize certain protein
segments (peptides) from scratch
and purify other proteins they
have "grown" themselves in the
appropriate culture medium.
These proteins and peptides are
dissolved, the solution is poured
into a glass vial, and the vial is put
into a ceramic holder before being
inserted into the NMR magnet.

� The dissolved protein molecules are subjected to intense
magnetic fields produced by a
supermagnet housed in the
apparatus. The greater the
strength of the field, the greater
the sensitivity of the measure
ments, and the magnet at
Rockefeller generates fields up
to 200,000 times stronger than
that of the earth. The strong
magnetic field causes the nuclear
"bar magnets" of certain atoms
such as hydrogen to line up in
one of two orientations.
Generally, the nuclei take the
orientation that requires the
least energy. But a boost of extra
energy in the form of radio fre
quency waves flips some of the
nuclear magnets into a higher
energy orientation. When these
excited nuclei revert to their for
mer, lower-energy state they
emit the absorbed radio energy,
which can be measured, record
ed, and analyzed by powerful
computers.
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The characteristic energy
absorption profile, or spectrum,
of each atom's nucleus depends
on many different factors in its
chemical environment, including
its own surrounding electrons
and the nuclei and electrons of
neighboring atoms. Typ ically,
NMR experiments are designed
to produce spectra that not only
identify individual atoms, but
give information about nearby
atoms, as well. Depending on the
experiment, these two-dimen
sional spectra may indicate which
atoms belong together in the
same amino acid or which ones,
though "unrelated," are close
together in space. Many NMR
runs are conducted to obtain the
massive amounts of data required
to characterize< all the atoms in a
protein. As one of the first steps
in analyzing this data, scientists
draw on their knowledge of
chemistry, physics, and mathe
matics, combined with their
knowledge of the protein's
amino acid sequence, to develop
a picture of the protein's "sec
ondary structure"-the twisted
helices and crimped, pleated
sheets that help give a protein its
shape.
With knowledge of the sec<Ill
ondary structure in hand, NMR
spectroscopists use interactive
computer programs to help them
derive a set of "conformers"-a
number of 3-D structures any
one of which might be correct.
Unlike x-ray crystallography,
NMR does not directly visualize
the atoms in a protein molecule,
but rather provides information
about the atoms' positions rela
tive to one another. The con
straints that determine these
positions lie within strictly
defined limits. The computer
program assesses the enormous
number of permutations that are
possible within these constraints,
and generates potential 3-D
structures. Many of these pro
posed structures violate the orig
inal NMR data in some way, and
the spectroscopists must analyze
and refine the models. For
instance, more than 100 struc
tures were originally generated
for the abl SH2 domain; in the
end, the Rockefeller researchers
identified twenty that best fit the
NMR data.

One or more of these structures
can be chosen for imaging with
powerful computer graphics pro
grams. Like x-ray crystallogra
phers, NMR spectroscopists use
programs that allow the images
to be moved and rotated in all
directions. These programs por
tray the protein's three-dimen
sional structure-the characteris
tic conformation of twists, pock
ets, and projections that endows
it with exactly the right combina
tion of chemical, mechanical, and
electrostatic forces to perform its
function. Researchers can select
any combination of the protein's
features-its sheets, loops, and
helices, its individual atoms, its
surface area, and its electric
charges-to focus in on particu
lar functional aspects they wish to
study. T
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Cracking Cancer's Secret Code
Hidesaburo Hanafusa and the One Genes

by John Langone
"All things are hidden, obscure, and debatable if the
cause ot the phenomena be unknown," Louis
Pasteur once observed. "But everything is clear if
this cause be known."
The words of the great French chemist readily
apply to cancer. For years, scientists and clinicians
knew it only as an insidious disease that ravaged the
body, but its central mechanism, the trigger that
propelled it along its fatal course, was a mysteryuntil about a dozen or so years ago, when cancer
was determined to be a disease of the genes, and,
more specifically, a disease spawned by a certain
group of genes. Known as oncogenes (from the
Greek, onkos, meaning "mass"), the first cancer
causing genes researchers discovered were a class
that started out as harmless as those that code for
our eye and hair color. The normal function of
these genes, now referred to as protooncogenes, is
to promote cell growth and division. Occasionally,
something-perhaps chemicals, radiation, or some
other physical carcinogen-damages their genetic
structure, and transforms them into the potentially
deadly oncogenes that promote the uncontrolled
cell growth that is cancer. Another class of cancer
causing genes-known as anti-oncogenes, or tumor
suppressor genes-has as its normal task the halting
of cellular growth; changes in these genes can also
result in the development of cancer.
DELVING INTO CELLULAR
TRANSFORMATION

But while the discovery of the cancer-causing genes
makes it possible to understand how cancer origi
nates, it does not in itself explain what jams a nor
mal gene's regulatory signals and converts it into a
hostile oncogene, nor how a turned-on oncogene
wreaks havoc in the cells. At The Rockefeller
University, a tumor virologist with a penchant for
protein chemistry, Hidesaburo Hanafusa, has been
unraveling the complex mechanism of cellular
transformation. Delving deeply into the molecular
basis of cancer, Hanafusa is, in a sense, an engineer
trying to determine the cause of a communications
breakdown: he searches for flaws in a cell's "wiring,"
for a malfunction in the equipment that sends,
John Langone, former medical writer at Discover and

Time magazines, is
working on a book about research and education at the Harvard Medical
School.

16

relays, and receives the chemical messages a cell
needs to function smoothly, for errors in the signals
themselves as they beam from within a cell, and
between cells. "There are," he says, "a lot of combi
nations, a lot of possibilities for some mistake. But I
think the progress we've all made in oncogenesis is
phenomenal. Gradually, too, we've learned more
and more about the key elements in all of this, the
proteins that can disrupt the cell's regulatory mech
anism."
Hanafusa's interest in cellular genes and onco
genesis-the topic of the series of Darwin Lectures
he delivered at Rockefeller in 1985-began some
thirty years ago, when he was working on the Rous
sarcoma virus as a postdoctoral fellow at the
University of California, Berkeley. It was 1961, a
time when the very foundations of molecular biolo
gy were being laid. Newly arrived from his native
Japan, where he received his B.S. and Ph.D. degrees
in biochemistry from Osaka University, Hanafusa
almost immediately took up where Peyton Rous,
who in 1911 had isolated the chicken tumor virus
that bears his name, left off.
STUDYING THE ROUS SARCOMA VIRUS

Rous had been invited in 1909 to The Rockefeller
Institute, as it was then called, to continue studies of
transplantation of tumors. Fortunately, he didn't
heed the advice of a mentor, who told him earlier
"not to commit deeply on cancer problems." A few
years later Rous described an infectious agent which
would turn out to be a retrovirus. But Rous didn't
pursue his find because cancer research was too
primitive, and there was little knowledge of viruses
in general, let alone the genetic materials that com
posed them. Indeed, the first electron microscopic
photographs of Rous's virus were not available until
1947. They were made at Rockefeller by Albert
Claude and Keith Porter.
At Berkeley, Hanafusa's interest in the Rous
virus peaked ("We had the technology now to pay
more attention to the implications of Rous's
groundwork," says Hanafusa), and soon he had
made several pioneering contributions that Rous

Rockefeller University, in his introduction to
himself would live to see. One was the finding that
for the Rous virus to replicate, it required a protein
Hanafusa's Darwin Lectures.
provided by a helper virus. This notion of a "defec
While the evidence for virus-induced cancers in
tive" Rous virus-defective in the sense that it was
humans is still lacking, viruses like the one isolated
unable to produce an essential envelope glycopro
by Rous have enabled scientists to analyze the
tein on its own-presaged what scientists refer to as
mechanism of cell transformation. Says Hanafusa:
transduction-the transfer of genetic material from
"Studies of these viruses have had a profound
one cell to another-of
impact on cancer research
oncogenes. After thl�y
when the viral genes
Hanafusa is, in a sense, an engineer
found oncogenes in viruses,
responsible for the trans
trying to determine the cause of a
scientists would also uncov
forming activity were found
er, in animal cells, genes
to have originated from cel
communications breakdown: he
with exact counterparts to
lular genes, the expression
searches for flaws in a cell's "wiring,"
the viral oncogenes. Re
of which is critical in carsearchers would also find
cinogenesis."
for a malfunction in the equipment
segments of DNA related
'
that sends, relays, and receives the
to the v-src oncogene in the
. INVESTIGATING THE
normal DNA of uninfected
ROLE OF THE SRC GENE
chemical messages a cell needs to
chickens. Today, scientists
For that reason, Hanafusa
function smoothly.
know that viruses can hijack
has long been interested in
bits of cellular DNA and
the v-src (pronounced
incorporate them, sometimes damaged, into their
"sark") oncogene that was originally found in the
own genetic material; and, more important, that
Rous sarcoma virus. The gene, like some other
cancer-causing genes are present in normal cells
oncogenes,
encodes a protein tyrosine kinase that is
before the cells �are infected by retroviruses. "If we
solely
responsible
for initiating and maintaining the
had pursued the basis of defectiveness," says
many different changes that accompany cellular
Hanafusa, "we could have reached the current idea
transformation. Hanafusa has been investigating the
of transduction of oncogenes much earlier."
role the src gene plays in the cell's signaling appara
(Hanafusa didn't do so because soon after he discov
tus, and where it gets involved along the signaling
ered the defectiveness of the Rous virus, some non
track. The signaling process is a complicated one
defective versions were found in viruses kept in
Europe. It turned out that they were, as Hanafusa
involving a chain of intracellular messages and
puts it, "exceptional viruses.")
interactions known as phosphorylation.
Hanafusa has found that upon infection with
Rous
sarcoma virus, many cellular proteins become
LEADING THE FIELD IN RNA
phosphorylated on tyrosine, which is associated
TUMOR VIRUS RESEARCH
with alterations in a number of cellular structures,
Hanafusa left Berkeley, and after stints as a visiting
and functions such as cell growth.
scientist at the College de France in Paris and as a
Hanafusa has also been hunting for a src-phos
member of New York City's Public Health
phorylated
protein that does its relay work on serine
Research Institute, he joined Rockefeller as a pro
or
threonine.
This one is most important because,
fessor in 1973. Perhaps it was his Ph.D. thesis
according to Hanafusa, serine/threonine kinases are
research on the protein chemistry of enzymes that
generally active close to the cell's nucleus, near the
spurred his later interests and accomplishments,
end of the signaling process. Hanafusa's team has
among them his descriptions of the mechanism of
discovered such a src-serine/threonine connection
genetic information in normal cells that comple
that may play a key role in cell regulation and which
ment defective viruses, and his isolation of mutants
might help to explain the runaway division process
that provided evidence for the role of a viral protein
that turns a cell savage and, thus, cancerous.
in transformation. Whatever it was, Hanafusa "has
Hanafusa has also identified a novel oncogene,
been the acknowledged leader in the study of the
erk, in an avian sarcoma virus, which was isolated in
genetics of RNA tumor viruses," observed Purnell
the early 1920s by Albert Claude, another pioneer
of cell biology at The Rockefeller Institute. It
W. Choppin, head of the Howard Hughes Medical
encodes a protein that has no known catalytic funcInstitute and former professor and dean at The
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Graduate student Heidi Greulich and her
faculty adviser, Hidesaburo Hanafusa,
viewina a colonv of transformed cells.

tion, but surprisingly induces tyrosine phosphoryla
tion of some cellular proteins, and causes cancer.
Just how the erk oncogene interacts with other pro
teins to transform a normal cell into a cancerous
one is currently under intense investigation, as is the
role of its mystery protein in normal cells. It is the
research of this protein that initiated the current
surge of interest in the _interaction between phos
photyrosine-containing proteins and a peptide
sequence known as SH2.
SETTING THE STAGE FOR
SOLVING THE CANCER PROBLEM

Hanafusa's research, like that of all scientists who
work at the molecular level, is not directly related to
the treatment of cancer. No more than one turned
on protooncogene relates to the transformation of a
healthy cell into a cancerous one. However, both
the research and the role of the oncogene are
steps-essential ones-toward something. The
activation of a protooncogene or the deactivation of
an anti-oncogene contribute to the development of
cancer amid a whole range of genetic changes, out
side influences, and collaboration with other genes
and oncogenes. The myriad molecular events that
are examined piecemeal in Hanafusa's and other
labs set the stage for successful treatment that will
surely come one day. Without basic research in cell
and molecular biology, biochemistry, and biotech
nology, it wouldn't be possible to make other
advances, such as drugs that block the interactions
or change the signals that contribute to a normal
cell's transformation to a cancerous one; drugs that
work against the protein products of oncogenes; or
a way to repair the machinery that has gone awry in
a tumor suppressor gene.
Hanafusa, like his colleagues in other
Rockefeller cancer labs, voices hope that these
advances will soon take place. Reflecting on his
years in the field, Hanafusa observes, "Since I start
ed to work in this area, there have been many sur
prises that will help us solve the cancer problem."
One indication that Hanfusa is the right man
for the job is the many awards he has received: the
Lasker Award for Basic Medical Research, the
Howard Taylor Ricketts Award, the Asahi Prize,
and the Clowes Memorial Award of the American
Association of Cancer Research. Another is the
description of the man and his contributions by one
of his fellow tumor virologists:
"Everything that Hide.saburo does has substan
tial impact on the field. He has a unique talent for
sensing the important, and avoiding the trivial." RU

Rockefeller's Transgenic
Service Laboratory
by Susan Blum

"Oh hi:�ve new world,
that has such people in't."
-Wtlliam Shakespeare,

The Tempest
The Rockefeller University's
new Transgenic Service Lab
oratory is a busy hub of activity
on the fifth floor of the
Laboratory Animal Research
Center (LARC). The lab serves
as the university's core facility
for the creation and mainte
nance of all transgenic animals,
the freezing and preservation of
mouse embryos, the refinement
and development of new trans
genic techniques, and the train
ing of university personnel.
Since the laboratory opened
recently, inquiry calls have been
coming in from research institu
ti on s around the country.
"We're unique in providing so
many different services in one
facility. People want to learn
more about what we're doing,"
says LARC director Michael
Hayre.
The interest is great because
transgenic techniques are play
ing an ever-increasing role in
biological research. These tech
niques allow researchers to
change an animal's natural
genetic endowment by adding or
subtracting virtually any genes
they desire. Such manipulations
permit a wide range of studies,
from basic research into a gene's
function to the creation of ani
mal models for diseases. So far,
most transgenic studies use
mice, but other animals such as
Susan Blum is a science writer in The
Rockefeller University Public Affairs Office.

birds and fish also offer promise
for productive investigations.
In one transgenic method,
the gene of interest is inserted
into fertilized mouse eggs, which
are then implanted into "surro
gate" mouse mothers. Some of
the offspring of these surrogates
carry the added gene in every
cell of their body. This method,
though extremely useful, can
present certain drawbacks. For
example, researchers cannot
control where the gene will be
inserted into each egg's chromo
somes, so they cannot be sure it
will have the same effect in
transgenic animals descending
from different eggs. A newer
transgenic method, called "gene
targeting," is more complicated
but allows for greater control.
By exploiting chromosomes'
natural propensity to shuffle, or
recombine, it allows researchers
to completely debilitate one of
an animal's normal genes or to
replace it with another of their
own devising.
The skilled staffers at
Rockefeller's transgenic service
lab are expert in both types of
transgenic techniques, providing
an unusual combination of capa
bilities that is a boon to re
searchers. The facility primarily
serves the Rockefeller communi
ty, but scientists from other in
stitutions are also welcome to use
it; researchers from as close by as
Memorial Sloan-Kettering Cancer
Center in Manhattan, and as far
away as the University of Hong
Kong, have already done so.
Transgenic techniques are
extremely demanding and time-

consuming. Now that the new
facility is open, researchers will
be able to enjoy the benefits of
the methodology without having
to cope with its complications.
"In most cases, if investigators
give us well-prepared DNA,
we'll be able to give them back
transgenic mice," says Anne
marie Walsh, director of the
Transgenic Service Laboratory.
For researchers who prefer to
perform the genetic manipula
tions in their own labs, the staff
of the facility stands ready to
provide any training that may be
required.
In addition to creating
transgenic animals, the facility. is
one of the few nationwide to
freeze and preserve transgenic
mouse embryos. This "cryo
preservation" cuts research costs
substantially-and reduces the
use of laboratory animals-by
minimizing the number of
breeding animals that must be
maintained. The technique also
ensures that genetically altered
lines of mice are protected from
the infections, accidents, and
"genetic drift" that can threaten
precious transgenic strains.
When transgenic mice are
required for research, the
embryos need only be thawed
and implanted in surrogate
mothers. Studies recently com
pleted in the lab show that cryo
preservation does not harm the
embryos in any way.
Lab members are also
researching better methods to
freeze mouse sperm-an accom
plishment that, like cryopreser
vation, would help save money

Above, Research Assistant Kirk Economides
microinjects mouse eggs with foreign DNA
to produce a new strain of transgenic mice
that will help researchers understand the

genetic endowment would fur
ther enhance the insights such
studies might provide. Though
the characteristic internal struc
ture of avian sperm and eggs has
so far thwarted the development
of transgenic birds, the team at
the Transgenic Service Labora
tory believes the obstacles can
ultimately be overcome.
Development of the Trans
genic Service Laboratory
was facilitated by a gift of
$150,000 from the Schering
Plough Research Institute, the
research division of the major
pharmaceutical company in
New Jersey. Michael Hayre has
long-standing ties with Schering
Plough, having served as the
company's associate director of
animal care before becoming
LARC's director in 1991. "We
are enormously pleased that
Schering-Plough has made such
a generous contribution to our
new facility," Hayre said. "My
ties of affection and admiration
for both Rockefeller and
Schering-Plough are enormous,
and I'm delighted that we have
been able to build this bridge be
tween the two institutions." RU
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and reduce the number of lab
animals used. It has long been
possible to freeze the sperm of
many other mammals from rats
to humans, but for reasons that
remain unknown the sperm of
mice is much harder to freeze.
The researchers at Rockefeller
are using new techniques devel
oped in England to surmount
the difficulties of this tricky pro
cedure.
That project is just one of
many now under way or planned
for the future at the new
Transgenic Service Laboratory.
Currently, for instance, Walsh
and Carol Novotney, a veteri-

22

nary postdoctoral fellow at
LARC, are exploring methods
to create transgenic quail. Most
other groups involved in such
efforts are interested in benefit
ing the poultry industry. But the
researchers at Rockefeller
believe transgenic birds would
be a boon to the biomedical
research community, too.
As the studies of Rocke
feller scientists such as Fer
nando Notte bohm and Arturo
Alvarez-Buylla have shown,
birds serve as excellent models
for neurobiological studies and
for research in basic biology.
The ability to manipulate birds'
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Top, Susan Powell, director of cryogenic preserva
tion services, retrieves a vial of frozen mouse
embryos. Bottom, Research Assistant Michelle
Inserra, left, and Annemarie Walsh, Pi{lht, director
of the Transgenic Service Laboratory, review data
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Dedication Ceremony

Keynote Address

by Walter E. Massey
Director, The National Science Foundation
I have often thought that if I had to live life over
again I would become a historian. I have made a
hobby of learning history because I believe passion
ately that we must know history in order to under
stand and appreciate current events, and to inform
our decisions about the future. In this new research
building, I see lots of history; and it also inspires me
to think about the future.
Both mystery and certainty are at work here.
We cannot predict what new knowledge will be
unveiled within the walls of this building. But we
also are certain that great advances will come forth
from within these walls sooner or later. Some man
or woman, perhaps someone here today, might
someday discover a cure for AIDS, or an affordable
pollution-free energy source, or any number of less
dramatic discoveries that bring added convenience
and enjoyment to daily life. This mystery-that we
cannot predict precisely what we will learn-com
bined with the certainty that great things will occur,
is the essence of scientific and technological
progress. It underlies all of the contributions that
science and technology have given to society
throughout history-from the first wheel to the
most advanced supercomputer.
I also believe that the historical importance of
this dedication extends far beyond this building and
the research it will house. This building is a vivid
reminder that science in America owes much of
its development to the farsighted individuals
who devoted their fortunes to the progress of
knowledge.
It staggers the mind to try to imagine what it
would take today to match the accomplishments of
the Rockefellers, Carnegies, Stanfords, and a gener
ation later, Hughes. Such individual largesse erected
universities, research institutes, and facilities that
enabled the nation to begin its ascendency in funda
mental science and engineering.
The dollar amounts behind these efforts of a
century ago-generally in the millions or tens of
millions-may not sound great by today's standards.
But it is worth remembering that when this great
institution was founded· in 1901, the entire Federal
budget totaled only a few hundred million (and, by
the way, it even ran a surplus in some years), a sue-
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cessful wage-earner might draw ten dollars a week,
and you could probably still find a good five-cent
cigar.
I give you these figures only to provide some
indication of how difficult it would be to duplicate
this generosity today. Yet without the wisdom and
foresight of these individuals, I am convinced that
America would not have been able to become the
wellspring of progress and knowledge that it is
today.
\Vhen this institution was founded, the Federal
government's interest in science and engineering
did not extend very far beyond surveying and map
making. Virtually all of fundamental research and
graduate education was supported by private and
philanthropic sources. Years later, when the govern
ment had matured enough to recognize the need for
a continuous supply of new knowledge and scientific
talent, the research infrastructure fortunately was
already in place. Since then, this research and edu
cation enterprise has laid the foundation for an
unbelievable string of discoveries, inventions, Nobel
Prizes, and economic progress.
Whenever an institution engages in a project of
this size and scope, it is natural and appropriate to
ask questions about the institution's future role,
mission, and responsibilities. I would like to offer a
couple of thoughts about the future of The
Rockefeller University.
First, never lose sight of the unique capabilities
of this institution. The value to the nation of a pure
research institution cannot be matched anywhere
else. By providing an unfettered atmosphere, the
nation's best minds are free to follow their imagina
tion and curiosity. It is truly amazing to have all of
this in the middle of the city that never sleeps.
Second, and closely related, is the fact that the
frontiers of science today often fall along the
boundaries of existing disciplines. The Rockefeller
University realized this early i n its history.
Although it was founded as a medical institute and is
still largely focused on human health, it recognized
the need to have scientists from other disciplines
physicists, chemists, engineers-on campus. This
has helped give rise to such promising areas of sci
ence as biophysics and biochemistry. The future of

science requires that this process of integration con
tinue, and I fully expect this university to remain at
the forefront.
I believe that this process of integration will be
a guiding force in the future for all of science. And
once again, my thoughts are inspired by what I have
learned about this building. Since I arrived on cam
pus to join in these festivities, more than one person
has said to me that this may well be last time we see
a research building of this capacity built entirely
with private funds.
The construction of this building combined the
forces of two names which are synonymous with the
can-do attitude that made America great:
Rockefeller and Hughes. The nation is very fortu
nate for that. But we have reached an age where
even with such stature behind the project, the end
result is just a shell in many respects. To put it sim
ply, somebody else has to buy the furniture for half
of the floors in this building.
I expect that the somebody who buys the furni
ture and instruments will be a combination of all of
us-government agencies like the National Science
Foundation and the National Institutes of Health,
the city and state governments may choose to par
ticipate, and without a doubt so will private corpo
rations and industrial groups that need advanced
knowledge for comparative advantage. The opening
of borders around the globe could also bring forth
new partnerships.
The challenge of furnishing this building is
symbolic of the future of the entire research enter
prise. I believe that the future of research will
involve increased cooperation, partnerships between
institutions, sharing knowledge, exchanging ideas,
and combining resources more than ever before.
There are changes occurring that make it clear
we cannot continue supporting research as we have
in the past. We are witnessing a growth in cost and
scale unlike anything in history: laboratories, like
the ones we see here for example, require the most
modern controls on wastes and emissions to comply
with government regulations. We have also moved
decades beyond the days when equipping a labora
tory was a simple as putting a microscope on a lab
bench.
And, when it comes to the administration of
research, sometimes it seems we are just running in
place. At NSF, we reject almost twice as many pro
posals as we fund. And those we fund receive only a
bare minimum in terms of support; the average
grant generally enables a senior scientist to hire just
one graduate student. Some people say more human

Above right, Walter Massey, Purnell Choppin,
and Torsten Wiesel at the dedication ceremony
for the John D. Rockefeller, Jr. and David
Rnrlrofollor l=loc-o::lrrh R11ilrlinn l::i�t �P.ntP.mhP.r

energy is expended reviewing research proposals
than conducting the research itself.
Despite these disconcerting facts, however, the
knowledge generated by investments in research
and education is more vital and valuable to the
nation than ever. There is great excitement about
the potential that many recent discoveries hold for
the nation's future: areas like superconductivity,
which could reduce energy consumption and lead to
new forms of transportation; or biotechnology,
which holds the promise of new drugs and tech
nologies to clean the environ�ment.
All of this adds up to a complicated picture of

the research enterprise as it approaches the twenty
first century-dynamic and vital, but also disgrun
tled and pessimistic.
The picture of the future of research would not
be complete without saying something about the
end of the cold war. No one of us can deny that
superpower tensions shaped many of our national
research and development priorities-from the
space race to Star Wars. Many disciplines, especially
in physics and engineering, grew up as offshoots of
weapons programs. Many areas of research in the
life sciences as well, including the human genome
project, have roots in national security objectives.
Even today, three years after the fall of the Berlin
Wall, almost sixty cents of every dollar the govern-
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ment spends on R&D is earmarked for defense, the
same level as a decade ago.
With the rapid decline of the Soviet Union at a
time of steady growth in economic power in Europe
and Asia, there are new expectations for research in
this country. Many of the underlying rationales for
public support of science are changing. At the
height of the cold war, people viewed science as
insurance against technological surprise from an
adversary. Today, the nation increasingly looks to
science as the source of the technological advance
necessary for economic prosperity and an improved
quality of life.
The research enterprise should not try to insu
late itself from these forces of change. To do so
would not only be a mistake, it would be impossible.
The future vitality of research depends on our abili
ty to be as creative and forward looking in the
future as people like John D. Rockefeller were a
century ago.
At the National Science Foundation, we have
begun a very thorough process of identifying the
most effective ways to continue serving the nation
and promoting the progress of science and engi
neering. I am certain that whatever NSF does in the
future must be premised on continued strong sup
port for the fundamental research that is so valuable
to the country. We must build on this strength and
help the nation capitalize on its preeminence in
fundamental science and engineering.
We must develop strategies that continue to
give academic researchers the independence they
need in order to achieve success. But we must do
more to move quality research quickly to those who
can use it for innovative applications. Cooperation,
integration, and exchange of ideas-this is the hall
mark of research in the future ...and also what I
believe will put furniture in this building.
John F. Kennedy once said that "History. . . has
no present, only the past rushing into the future. To
try to hold fast is to be swept aside."
The dedication of this building gives us the
chance to celebrate a slice of the history of science
in America. It also serves as a reminder of the chal
lenges and opportunities that the future will bring.

....

26

Above left, The Rockefeller Research Building
rlRrlir.::itinn rP.rP.mnnv �P.ntP.mhP.r 1 qq7

The Rockefeller University and
The Hovvard Hughes Medical Institute

Collaborating to Further
Scientific Discovery

The opening of the John D.
Rockefeller, Jr. and David
Rockefeller Research Building
marks a major collaboration in
modern science. The structure
symbolizes the joined forces
and shared philosophy-of two
prominent institutions dedicated
to biomedical research-The
Rockefeller University and the
Howard Hughes Medical
Institute (HHMI), the largest
private philanthropy in the
nation, which contributed over
$3 3 million to the cost of the
new building. Says Torsten
Wiesel, Rockefeller's president,
the institutions' common out
look "strikes to the heart of the
whole scientific enterprise: Find
the most talented researchers
possible, and then give them the
facilities and the freedom to pur
sue their studies wherever they
might lead."
The collaboration is particu
larly meaningful for both institu
tions because HHMI's president,
Purnell W. Choppin, spent much
of his career as a research scien
tist, dean, and scientific administra
tor at The Rockefeller University.
"Among those to whom this
occasion means something very
special I certainly count myself,"
said Choppin at the building's
dedication ceremonies last
September. "I cannot avoid
some very personal feelings

Right, Purnell Choppin, head of the Howard
Hughes Medical Institute (HHMI). and his
wife, Joan, flank Nathaniel Heintz in his labora
tory in the new Rockefeller�research building.
Heintz, an HHMI investigator, was the first uni
versity faculty member to move his lab into the
nnw fof'ilit11 f11nrlorl in n'.:lrt thrn11nh 1-ll-H,AI

because I have been privileged
to have long personal associa
tions with both the very special
place that The Rockefeller Uni
versity is, and another unique
and great institution, the
Hughes Institute."
Before joining HHMI as
vice president and chief scientific
officer in 1985, Purnell Choppin
spent twenty-eight years at The
Rockefeller University studying
the mechanisms by which
influenza and measles viruses
produce cell injury and disease.

When he left the university he
was a senior physician and the
Leon H�ss Professor of Virol
ogy, and served as vice president
for academic programs and dean
of graduate studies.
"Clearly my years there
imbued me with respect for
thoroughness and excellence,"
Choppin explains, "and the
importance of unfettered time to
perform research. If one comes
from an institute of that order,
he looks on research with the
highest possible standards."

HHMI SUPPORTS
RESEARCH AND
LAB SPACE

The relationship between The
Rockefeller University and The
Ho ward Hughes Medical
Institute exemplifies HHMI's
method of support. Once
HHMI enters a collaborative
agreement with a host institu
tion, it not only brings faculty
scientists onto its research stiff,
but arranges for their laboratory
space either by leasing existing
faciliti es or by participating
financially in the construction of
a new building and then occupy
ing some of the new facilities.
An arrangement for new con
struction was reached between
Hughes and The Rockefeller
University at the time of their
contractual agreement in 1985.
At that time, HHMI pledged

funds toward four floors of the
new research facility that opened
its doors this fall.
"There is no other institu
ti on in the United States that
operates quite like Hughes," says
Choppin. "As an operating med
ical research organization,
HHMI enters into partnership
with outstanding universities and
medical centers, collaborations
to which each brings important
resources-human, environmen
tal, and financial. It is an unusual
arrangement in which HHMI
investigators become Institute
employees but remain as faculty
members of the host institutions,
carrying out normal teaching
and other faculty responsibili
ties. It is complex, but it works
and we at HHMI are apprecia
tive of the manner in which our
partners, such as The Rocke
feller University, work with us."

ELEVEN RU SCIENTISTS
ARE HUGHES
INVESTIGATORS

At Rockefeller University, the
Howard Hughes Medical Institute
supports eleven scientists whose
research will soon be carried out
on four floors of the n�� John
D. Rockefeller, Jr. and David
Rockefeller Research Building.
HHMI selects investigators
according to the quality of their
research. Scientists do not apply
for HHMI support; they are
chosen. They are offered renew
able appointments for varying
periods of time, depending on
the rank of the scientist at the
host institution. Assistant profes
sors are appointed for terms of
three years, associates for five
years, and full professors for
seven years. HHMI investigators
heading labs at Ro ckefeller
University are Gunter Blobel,
S tephen K. Burley,· C laude
Desplan, Michael W. Young,
Thomas Sakmar, Michel C .
Nussenzweig, Jeffrey M.
Friedman, Nathaniel Heintz,
John Kuriyan, Jan Geliebter, and

Right, Peggy and David Rockefeller enter
the new Rockefeller research tower after the
ribbon-cutting ceremony at the building's

Yongwon Choi. An additional
eighty-one people-postdoctoral
associates, technicians, and other
support staff-who work on the
Rockefeller campus are on the\
Hughes payroll. In fiscal year
1992, HHMI's operating budget
for its Rockefeller University
projects was $7 .8 million,
according to Choppin.
"Hughes is very generous,"
says geneticist Michael Young.
"The institute takes you in and
gives you ample support that is
realistic to the cost of science.
There is money for supplies and
salaries for junior members of
the lab. Postdocs can work on
two-, three-, or four-year inde
pendent projects that relate to
the larger project, and Hughes
pays for their work and supplies.
Money from public and private
agencies is tight now and a grant
is often barely enough to cover a
portion of your work. Hughes is
more realistic and has more
awareness of the costs of
research."

A VISION FOR THE FUTURE

The joint efforts of HHMI and
The Rockefeller University are
expected to result in significant
contributions to scientific
research. Walter E. Massey,
director of the National Science
Foundation, said in his keynote
address at the dedication cere
mony for the new building
(reprinted in its e ntirety on
pages 24-26): "Both mystery and
certainty are at work here. We
cannot predict what new knowl
edge will be unveiled within the
�alls of this building. But we
also are certain that great
advances will come forth from
within these walls sooner or
later. Some man or woman, per
haps someone here today, might
someday discover a cure for
AIDS, or an affordable pollu
tion-free energy source, or any
number of less dramatic discov
eries that bring added conve
nience and enjoyment to daily
life." That is the hope-and the
anticipatio n-of this philan
thropic missio n that David
Rockefeller says is "aimed at
supporting top-quality re-search
that only the very best in science
are qualified to conduct."

F
rotn
Microbes
to
Molecules:
A CENTURY OF SCIENCE AT THE,ROCKEFEiLER UNIVE

Above, Schermerhorn Farm: Site of the future Rockefeller
University campus. Inset, Frederick T. Gates and Simon Flexner.

The Rockefeller Institute for
Medical Research was incorpo
rated in 1901, and immediately
gained local attention by finding
(as the headlines of the New York
Herald put it) "Germs Swarming
in City's Purest Milk." The next
year, Simon Flexner, a young,
eminent pathologist at the
University of Pennsylvania, was
appointed the nascent institute's
first director. It was Flexner's
personal venture into the uni
verse of deadly microbes during
a 1 904-1905 epidemic of cere
brospinal meningitis that estab
lished both The Rockefeller
Institute's lasting fame and the
enduring confidence of its bene
factor, John D. Rockefeller.
Text by Geoffrey Montgomery
Photos are courtesy of The
Rockefeller University Archives
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Dr. Holt Explains Why lnsti�
tute Gets New Hospital from
Jo-hn D, RockefelleL
MENINGITIS CURE DID IT
Through New Discovery 70 to
75 Out of Every 100 Re
cover from Disease.

American, New York City, June 1, 1908.
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Under the leadership of this
master microbe hunter, the mis
sion of The Rockefeller Institute
both widened and deepened. fn
1910, as construction was com
pleted on a new hospital,
Flexner recruited the experi
mental biologist Jacques Loeb,
an apostle for a physico-chemi
cal explanation of life's great
c o nundr u m s - h e r e di t y,
embryogenesis, and mind. One
of Flexner's first appointments
to Rockefeller, Phoebus Levene,
revealed the chemical formulas
of the ill-understood nucleic
acids . And in 193 5, Wendell
Stanley, applying methods
developed by his Rockefeller
colleagues working on protein
chemistry, succeeded in crystal
lizing the virus responsible for
tobacco mosaic disease.
Stanley's crystalline micro be
caused a sensation. This virus
that could be turned to crystal
while retaining its self-replicat
ing powers seemed to exist on
the twilight border between the
living and the dead, between
reproducing organisms and life
less molecules. Its protein cap
sule seemed to hold the promise
of a true chemical understanding
of life. Stanley, like Loeb,
Levene, and nearly all bio
chemists of the age, thought that
the elements of reproduction
genes-must be made of pro
tein. Yet a strange fact soon
emerged. Coiled within the cap
sule of Stanley's magic crystal
was the molecule Levene had
first analyzed-a nucleic acid.

The cornerstone of Founder's
Hall, which housed The
Rockefeller Institute for
Medical Research's first permanent laboratories, was
laid on December 3, 1904.
The lnstitute's Board asked

for a building that would be
commodious but without
frills: its style should "be as
simple as is consistent with
its present purpose, future
additions, and general utility."
Founder's Hall was

opened on May 11, 1906.
Within its six floors of brick
and stone resided three
departments that represented
the core disciplines of the
early institute: chemistry,
pathology, and bacteriology.

President Oetlev W. Bronk,
with Board Chairman David
Rockefeller, led the
institute's evolution into
a university. In 1954
Rockefeller was given the
power to grant graduate

degrees by the University of
the State of New York.
Caspary Hall/Abby
Aldrich Rockefeller Hall-a
single integrated building
despite its dual name-was
completed in 1958. It con-

tains the office of the president
and other administrators, a
small library, the Faculty and
Student's Club, a dining room,
and guest accommodations.
Connected to Caspary is the
university's domed auditorium.
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First electron micrograph of a cell.

While Avery the microbe hunter
discovered that DNA is the stuff
genes are made of, another mi
crobe hunter, Albert Claude, led
science's entry into the fine
structures residing in the cell's
gelatinous interior. Trying to
isolate the famous cancer-causing
virus that Peyton Rous had dis-

covered in 1913, Claude pio
neered in the 1940s the dual
deployment of electron micros
copy and biochemistry in unveil
ing the invisible world of the
cell. In the mid-1950s, extending
the work of Claude and Keith
P orter, George Palade and
Philip Siekevitz uncovered key
aspects by which DNA's code is
translated into proteins-the
cogs, gears, and girders by which
cells function.
For founding modern cell biolo
gy, Claude, Palade, and Christian
de Du ve shared the 197 4
Nobel Prize for Physiology or
Medicine.

Ribosomes-factories for making proteins.
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Bruce Merrifield and his protein synthesizer.
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SH2 domain coded by Rous sarcoma virus oncogene
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In 1972 Stanford Moore and
William H. Stein received the
Nobel Prize for their chemical
analysis of the protein ribonu
clease; and in 1984 Bruce
Merrifield won the Prize for
artificially synthesizing this same
protein . Between 1940 and
1980, Rockefeller scientists voy
aged from the center of the cell
and its DNA to the vital protein
structures DNA encodes.
In addition, the discoveries of
Rockefeller's earliest microbe
hunters continue to bear fruit.
Just this summer, in a seminal
collaboration, the labs of four
Rockefeller professors-David
Balti more, David Cowburn,
Hidesaburo Hanafusa, and John
Kuriyan-along with Marilyn
Resh of the Memorial Sloan
Kettering Can cer Center
revealed the crystal structure of
a key cancer-causing protein
segment, is olated from the
tumor virus Rockefeller scientist
Peyton Rous first cultured
eighty years ago. Through such
work from its current re
searchers, Rockefeller's glorious
past remains very much alive.

In 1971, the Mary Flagler
Cary Charitable Trust
donated a tract of land in
Millbrook, New York, that
now serves as the univer"
sity's Field Research Center
for Ecology and Ethology.

The John D. Rockefeller, Jr.
and David Rockefeller
Research Building was
opened in 1992.

1991-92 Annual Report
Frotn the President
by Torsten Wiesel
Just over a year ago I accepted the responsibility of
$28.5 million in fiscal 1991-92, and this growth has con
becoming_ president of The Rockefeller University. Most
tinued in the months thereafter.
of my nearly forty years as a scientist had been devoted to
The first decades of _this university's existence happi
research; my previous administrative experience consisted
ly coincided with the development of an entirely new
of serving as chairman of the Harvard Medical School's
field, molecular biology, which brought together the skills
neurobiology department, as well as a few other small
and insights� of medical scientists, biologists, chemists, and
assignments. Yet my transition from
physicists. Through gene therapy and
the laboratory to the president's office
molecular medicine, molecular biology
The university's finances
went smoothly, thanks in no small
now offers a remarkable and unprece
part to the relationships I had formed
dented range of diagnostic technolo
have been greatly
in my decade on the Rockefeller facul
gies and treatment possibilities for
strengthened, and we
ty. The faces on the campus were
many of our most-feared diseases: can
familiar; many belonged to close col
cer, AIDS, heart diseasf, and antibiotic
have been able to recruit
leagues and friends. These personal,
resistant tuberculosis, to name only a
an outstanding senior
trusting relationships, especially with
few. This new era of molecular medi
members of the faculty and the
professor and five superb cine was born at The Rockefeller
trustees, provided a solid foundation
University Hospital, and we continue
junior professors.
for leading this university.
to allocate resources to revitalize the
I have been fortunate: this has
hospital and keep it at the forefront of
been an-auspicious period for Rockefeller. The universi
this ever-expanding scientific frontier. In February 1992,
ty's finances have been greatly strengthened, and we have
Zanvil Cohn was appointed Vice President for Medical
been able to recruit an outstanding senior professor and
Affairs; at the same time, Jules Hirsch became the hospi
five superb junior professors. The Rockefeller University
tal's Physician-in-Chief, and Rudy Leibel, a longtime col
Hospital has received new leadership and new resources;
laborator with Dr. Hirsch in studying the biological basis
we have added a sixth faculty search committee, in
of obesity, was named Head of Laboratory. A challenge
physics; and we have witnessed the opening of our mag
grant from the Herzog Foundation provided crucial sup
port for our Clinical Scholars Program, which furthers
nificent new tower, the John D. Rockefeller, Jr. and
the careers of outstanding physician-scientists. These
David Rockefeller Research Building, with 50,000 square
developments, as well as the efforts o{our search commit
feet of laboratory space ready for immediate use, and
tee for medical scientists, will help to maintain the hospi
�nother 50,000 to be developed on the top six floors.
tal's central place in this essential field.
These successes, of course, did not arrive miracu
lously in this first short year of my presidency; they were
The university continues to expand its basic core
planned, prepared, and begun under the leadership of my
areas of biomedical research. Three members of our fac
predecessors, Joshua Lederberg and David Baltimore, and
ulty have been promoted to Head of Laboratory: the
were nourished by the crucial support of the Howard
structural biologist David Cowburn, the medical
Hughes Medical Institute. Under Dr. Baltimore's admin
researcher Shigeru Sassa, and · the cell biologist Sanford
istration, Fred Bohen, our executive vice president,
Simon. Three scientists from outside the university have
helped to chart a sound course for The Rockefeller
been appointed to our junior faculty: Kenji Adzuma, a
University's financial future by setting in place a coordi
molecular geneticist; Yongwon Choi, an immunologist;
nated program of management and financial reforms.
and Seth Darst, a structural biologist. Our search com
This tougher-minded allocation of the university's
mittees in biochemistry, chemistry, and structural biolo
resources has continued during my presidency, and it has
gy, in cell and developmental biology, and in immunology
already resulted in a striking decrease in our operating
and microbiology continue to seek out outstanding junior
deficit-the shortfall between income and expenses that
and senior faculty to join us at The Rockefeller
has eroded the university's financial strength over the last
University. I have always felt that it is important for the
five years. At the same time, the gifts and pledges given to
university to maintain and develop our small but active
the university from private sources have increased dra
chemistry and physics programs, and two visiting com
matically, rising from $11.3 million in fiscal 1990-91 to
mittees have conc�rred with me. The university's core
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mission remains biomedical research, but as I mentioned
above, the participation of physicists and chemists has
been crucial to the revolution in cell and molecular biolo
gy, and the presence of physical scientists will remain an
essential part of our scientific community.
Most biomedical scientists will agree with me when I
say that the next great biological frontier is an increased
understanding of the workings of the brain, the most
complex organic structure in the known universe. The
Rockefeller University is already among the world's fore
most research facilities in neuroscience, with top-notch
laboratories investigating the basic mechanisms underly
ing perception, memory, learning, development, and such
disorders of the brain
as depressive illness,
schizophrenia, and
Alzheimer's disease.
We have a search com
mittee in neurobiology
seeking neuroscientists
whose work will com
plement that of our
laboratories. The com
mittee's activity has
already led to the
appointment of two
new junior faculty
members: Robert Dar
nell, whose research on
the brain sheds light on
problems in immunol
ogy and cancer, and
Joseph Atick, a young
physicist who is devel
oping mathematical
models of sensory per
ception. A major initia
tive of my administration has been the development of a Neuroscience Center,
to be housed in our new research building, which will
integrate and strengthen the university's efforts in neuro
biology. The newest member of our senior faculty
Mary Beth Hatten, a leading developmental neurobiolo
gist-will play a key role as part of this interactive
research center.
The creative life of our scientific community requires
a strong administrative and support team, and here, too,
the past year has brought us great successes. We were
able to attract a superb and experienced administrator,
Ingrid Reed (who was formerly at Princeton's Woodrow
Wilson School), to assume the critical roles of Vice
President for Public Affairs and Corporate Secretary.
Ingrid serves as liaison among the Board of Trustees, the
faculty, and the Office of the President; in addition, she

Above, President Torsten Wiesel talks with stu...i,,.,+" nn Thn Rn,-.l,ofollor I lniHorc-ih, r::imn1 IC'

organizes publications, lectu.res, and special events for
general audiences as part of an ever-growing effort to
reach out to the larger community of which our university
is a part. (Our high school outreach program for science
education, which was formally instituted last May, is
another critical component of this effort.) Frank Lees, our
new Chief Information Officer, comes to us from the
State University of New York in Albany. He has already
emerged as an important member of the university's staff
through his help in integrating the campus's computer
and communication-services networks.
In my first year as president, I have discovered how
fortunate we are to have a Board of Trustees that is gen
uinely committed to
the scientific and
operational principles
on which the universi
ty was founded. David
Rockefeller has served
on the board for over
fifty years, and the
steadfastness of his
leaders�ip and support
should serve as a
model for all other
research universities.
Richard
F urlaud,
Chairman of
the
Board of Trustees, has
been a friend, a part
ner, and a constant
source of guidance. I
would like to welcome
those trustees who
have recently joined
our board: Edward S.
Cooper, D. Ronald
Daniel, Evelyn G. Lip
per, Ernest Mario, Frederick A Terry, and Alair Townsend.
One of my great pleasures in this past year has been
the opportunity to meet and work with people from every
part of the university: trustees, faculty, students, adminis
trators, and support staff. I believe we are all working
together in harmony and with a sense of common pur
pose. As we look toward the future in an ever-changing
and increasingly competitive world, we must continue to
set our goals high and be guided by the compass of the
past. Discoveries at The Rockefeller University have
played a crucial role in changing the course of scientific
history: they have added to our understanding of nature
and of human disease, and have laid the foundations for
contemporary molecular medicine. Our task is to build on
these achievements and, through our efforts, enhance this
noble legacy for those who succeed us.
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1991-92 Annual Report
From. the Executive Vice President
by Frederick M. Bohen
The Rockefeller University accomplished several major
operational objectives during the course of 1991-92, even as
presidential leadership passed, without advance planning but
nonetheless smoothly and cordially, from Dr. David
Baltimore to Dr. Torsten Wiesel. The university measurably
strengthened its financial foundations by significantly cutting
its operating costs and achieving dramatic advances in private
fund-raising for research.
Among the operational highlights of the year, the university:
•
Completed construction in June 1992 of a state-of-the
art, twelve-story research facility-the John D. Rockefeller,
Jr. and David Rockefeller Research Building. This extraordi
nary $88 million facility adds 100,000 square feet to the uni
versity's productive research space, increasing it by more
than 30 percent. The building was completed in less than 24
months, slightly ahead of schedule, and more than $4.5 mil
lion under the total budget authorized by the university's
trustees.
• Consummated the first combined taxable/tax exempt
long-term debt financing undertaken by an institution of
higher education in New York State. With the assistance ,of
the New York Dormitory Authority, the university borrowed
$50 million in July 1991, to cover its share of the construc
tion costs of the new Rockefeller Research Building, at a
blended taxable/tax exempt interest rate of 7.1 percent. Even
after this $50 million debt issue, the university's very favor
able endowment-debt ratio continues to place it comfortably
among the half-dozen research universities in the nation with
the strongest balance sheets, and sustains its Triple-A credit
rating.
•
Purchased and installed a new AT&T-manufactured
telephone system which replaced a creaky rented system that
had lasted for more than a decade. The university simultane
ously recabled the campus with high-capacity fiber-optic
wire that provides a backbone network for state-of-the-art
information and computing services. These improvements
were accomplished through financial arrangements that held
future annual amortization of the capital investment involved
below the annual cost of the equipment and services that
were replaced.
•
Invested more than $1.1 million, including a major
grant from NIH, to upgrade the heating, ventilation, and air
conditioning systems and made other physical plant
improvements in the Laboratory Animal Research Center
(LARC). These improvements will ensure that the university
maintains an outstanding animal care and use program.
In April 1992, Dr. Michael Hayre, the Director of
LARC, and his staff, received a three-day reaccreditation
review and assessment by The American Association for
Accreditation of Laboratory Animal Care (AAALAC). The

university's strengthened program and improved animal
based research facility won high marks and received contin
ued full accreditation.
• Modernized research laboratories in the Tower
Building; expanded the protein sequencing service facility in
the Smith Hall research building.
Successfully renegotiated with the federal government
•
the university's rate for reimbursement of necessary over
head and research support costs, following extensive inde
pendent audits for the years 1986-90 that revealed no mater
ial overbilling of the government for unauthorized or inap
propriate expenses.
Fiscal year 1991-92 also marked the moment when the
university decisively narrowed the gap between overall
expenses and income that had widened steadily during the
five previous years. As illustrated by the graph that accompa
nies this report, the shortfall between income and expenses
grew from $11.6 million in 1988-89 to $14.0 million in
1989-90, and $15 .8 million in 1990-91 before dropping
sharply to $8.6 million in 1991-92. This movement toward financial balance is expected to continue in 1992-93.
Also in 1991-92, the university's fund-raising from pri
vate sources ( organized foundations, individual donors and
private corporations) soared to an historic high of $28.5 mil
lion in new gifts and pledges. This compared favorably with
$9.1 million in 1989-90 and $11.3 million in 1990-91. The
dramatic increase in funds from private resources not only
helped reduce the annual operating deficit, but enables the
university to continue a multi-year process of expanding and
strengthening its faculty.
The university's record achievement of $28.5 million in
new gifts and pledges during 1991-92:
•
resulted in cash receipts of $17.9 million, an increase of
$4.9 million, or 38 percent above the level of the previous
year;
•
added $11. 7 million in current and future gifts to
strengthen our permanent endowment;
•
enabled the university to plan continuing recruitment
and expansion of the research faculty by assuring $7.6 mil
lion in new gifts that will be received in the years immediat_e
ly ahead, and will be applied to underwrite the university's
plans to expand its research faculty.
The university received several seven-figure leadership
gifts which reflected an increased outreach to new
friends led by members of the Board of Trustees, The
Rockefeller University Council, and the Committee on
Trust and Estate Gift Plans:
•

a $2 million challenge grant from a current trustee to
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members of the RU Council to double the private giving
over the next two years by attaining a $10 million goal.
During FY92, the first year of the challenge grant period,
Council giving reached a record $5 million, representing a
doubling from prior years;
•
a $1. 9 million challenge grant from The Carl J.
Herzog Foundation to raise endowment funds for the
Clinical Scholars Program at The Rockefeller University
Hospital. The grant provid½p $1 for every $2 contributed to
the endowment by other university friends;
•
$3.6 million for arthritis and diabetes research from a
trust which paid a donor lifetime income and terminated on
her death, and a $1 million bequest in support of research
on schizophrenia. Both gifts were made possible by the
superb efforts of volunteers from the university's
Committee on Trust and Estate Gift Plans.
While dramatically stronger fund-raising has been
essential to the university's financial turnaround, so, too,
has been a determined effort to control and reduce expens
es-to make do with less-in all facets of university opera
tions, especially in administration and support services.
Initiated by former President David Baltimore, and firmly
continued and enforced by President Torsten Wiesel, .this
"austerity" initiative asked everyone in the Rockefeller
community to share in sacrifice by forgoing routine salary
increases for academic year 1991-92, to live with the limita
tions and frustrations of an employment freeze, and to
engage cooperatively in office-by-office reviews that would
rationally, carefully, but decisively downsize both the scale
of functions, activities, and services, and the university's
investment to support them. The result of this "austerity"
initiative (as illustrated in the table accompanying this

report) is that the university's total expenditures of $107
million in 1991-92 dropped $6.5 million below the amount
spent in 1990-91.
Within this overall framework of cost limitation and
reduction in 1991-92, the-university reduced:
•
the annual costs of general administration and institu
tional management from $13.7 million to $12.3 million
an absolute reduction of 10 percent;
•
the annual costs of Facilities Management and
Planning from $14.9 million to $14.3 million-an absolute
reduction of 4 percent;
•
the annual costs of auxili;ry service functions, particu
larly residential housing and food services, from $15.9 to
$14.9 million- an absolute reduction of 6.3%;
• expenditures for routine capital needs from $4.8 mil
lion to $1.2 �illion-an absolute reduction of 75 percent.
As it faces the scientific challenges and opportunities of
the future, the university has the continuing need to con
tain and cut its overhead and support expenses, to constant- '
ly test concepts of improved or enhanced services against
the discipline of "affordability," and to focus new adminis
trative expenditures on support needs of the university
community that simply must be met. In the new environ
ment of scarcity, controlled management of resources is not
merely desirable, but absolutely essential and inescapable.
The university's leadership believes it met this demanding
standard during 1991-92. It looks to the future with confi
dence in .its capacity to protect and advance the university's
scientific quality, while sustaining the recent gains in finan
cial stability and strength.

Statement of Expenditures and Resources Utilized

Five Years Ended June 30, 1992
(000's omitted)
1988

1989

1990

1991

1992

$59,100
Research and education
12,300
Operations and maintenance of plant
General administrative and institutional 10,400
11,100
Auxiliary enterprises
1,200
Debt service
8,600
Capital expenditures

61,200
14,100
12,000
12,400
1,200
7,700

63,600
14,600
12,800
14,700
1,300
4,500

62,900
14,900
13,700
15,900
1,300
4,800

63,000
14,300
12,300
14,900
1,300
1,200

$102,700 108,600

111,500

113,500

107,000

$37,700
19,500
24,200
8,500
3,100

41,500
18,300
24,500
9,600
3,100

37,100
20,100
25,000
12,200
3,100

36,800
18,700
25,100
13,800
3,300

38,000
17,400
24,400
14,300
4,300

$93,000

97,000

97,500

97,700

98,400

Expenditures

Total Expenditures

Resources Utilized

Government grants and contracts
Private gifts grants and contracts
*Endowment income
Auxiliary enterprises
Other sources
Total income

Financial Summary

Five Years EndedJune 30, 1992
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Total Resources Utilized

11,600

14,000

15,800

8,600

$102,700 108,600

111,500

113,500

107,000

9,700

*Endowment income is defined as five percent of a three-year average market value
The University uses annual audited statements. A copy for 1992 can be obtained from
the Controller's Office, The Rockefeller University, 1230 York Avenue, New York, NY 10021.
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Pledges and Gifts
to Operating
Support and Facilities
July 1, 1991-June 30, 1992
Foundations and
Individuals
Mr. & Mrs. Ralph E. Ablon
AE Charitable Foundation
Altman Foundation
American Medico-Legal Foundation
The Annenberg F51undation
Anonymous
Archbold Charitable Trust
ARCS Foundation, Inc.
The Vincent Astor Foundation
Dr. Jesse Huntley Ausubel
Mr. Mal L. Barasch
Mr. Charles F. Barber
The Theodore H. Barth Foundation
Mr. & Mrs. Robert M. Bass
Dr. & Mrs. Alexander G. Bearn
Arnold and Mabel Beckman Foundation
Dr. Paul Berg
Mr. David Blech
Jacob Bleibtreu Foundation Inc.
The Sol Bloom Family Foundation, Inc.
Mr. & Mrs. Steven Bloom
Edith C. Blum Foundation
The Bodman Foundation
Mr. Frederick M. Bohen
Botwinick-Wolfensohn Foundation, Inc.
Mrs. Patricia S. Bradshaw
Dr. Ronald Breslow
BTW Fund of the NY Community Trust
Llewellyn Burchell Charitable Trust
Mr. Walter Burke
The Louis Calder Foundation
Mr. & Mrs. Paul A. Cameron
Mr. Robert Cane
Dr. Ronald E. Cape
Carnegie Corporation of New York
Mr. & Mrs. Robert Carswell
Mary Flagler Cary Charitable Trust
Mr. & Mrs. Lauriston Castleman
Monique Weill Caulier Trust
Mr. Guy J. Charlap
Mr. & Mrs. Gustavos A. Cisneros
Mrs. Helen Comando
Mr. Daniel I. Cooper
Council for Chemical Research Inc.
The Cousins Foundation, Inc.
Mrs. Susan L. Cullman
Mr. Robert N. Davies
Mr. Philippe de Fiers
Ms. Kathryn M. Deane
Mr. & Mrs. J. Richardson Dilworth
The Dreitzer Foundation, Inc.
Dr. Anne E. Dyson
Mr. Harvey C. Dzodin
Mrs. Marie N. Eising
The Enzyme Club

The Rockefeller University
Development Program
New Gifts and Pledges
Fiscal Years 1988-1992
(in millions)
30

25

20

15
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·5

FY88

FY89
Trustee
Campaign
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FY90

FY91

FY92

Ms. Eve Epstein
Mrs. Angeles Espinosa Rugarcia
Mr. C. Sims Farr
Mr. & Mrs. Bernard Finkelstein
Mr. & Mrs. Edward S. Finkelstein
Forbes Foundation
Mr. Alexander D. Forger
Mr. Leonard Franklin
Dr. & Mrs. Eugene Fubini
Mr. Frederic J. Fuller
Mr. Richard M. Furlaud
Mr. & Mrs. Edward L. Gardner
Dr. William C. Gibson
Golden Family Foundation
Herman Goldman Foundation
Ms. Neva R. Goodwin
Grand Street Boys· Foundation
Hagedorn Fund
Francena T. Harrison Foundation Trust
Dr. & Mrs. Caryl P. Haskins
Mr. Peter R. Hauspurg
Mrs. Eleanor Marino Hawkins
Mr. & Mrs. Norman M. Henderson
Ms. Judith F. Hernstadt
The Carl J. Herzog Foundation, Inc.
Dr. Heisuke Hironaka
Mr. & Mrs. Shinya Hirota
Henrietta Hirsch Trust
Mack J. Hirsch Trust
The Irma T. Hirschi Trust
Ms. Janet E. Hunt
Ms. Katharina Jaeckh
Jephson Educational Trust No. 2
Robert Wood Johnson, Jr. 1962
Charitable Trust
Mrs. Helene L. Kaplan
Mr. & Mrs. Joseph Kartiganer
Mr. John J. Kindred 111
Mrs. Nancy M. Kissinger
The Esther A. and Joseph
Klingenstein Fund, Inc.
Or. Antonie T. Knoppers
Mr. Pedro-Pablo Kuczynski
Eugene M. Lang Foundation
The Jacob and Valeria
Langeloth Foundation
Dr. Philip Leder
Ors. Joshua & Marguerite Lederberg
Dolores Z. Liebmann Trust
Mr. & Mrs. Edmund W. Littlefield
Mr. Alexander MacN. Luke
Mr. Ira H. Lustgarten
Mr. & Mrs. John D. Macomber
Dr. Ernest Mario
Lucille P. Markey Charitable Trust
Donald B. and Catherine C.
Marron Foundation
Abby R. Mauze Charitable Trust
William & Helen Mazer Foundation
Mrs. Carlyn S. McCaffrey
Dr. & Mrs. Maclyn McCarty
Mr. Thomas K. Mccaughey
Mr. John J. McDermott
The McIntosh Foundation
Mrs. Esther H. Miller
Estate of Fay Minkowich
Edward S. Moore Foundation, Inc.
Mr. Jeffrey-Paul Nash
Samuel 1. Newhouse Foundation Inc.

Mr. Albert L. Nickerson
Mr. Phil R. North
Mr. & Mrs. Donal C. O'Brien, Jr.
Dr. & Mrs. Ralph A. O'Connell
Mr. John J. O'Grady Ill
Abby and George O'Neill Trust
Mr. Milton Okin
Ms. Dorinda J. Oliver
The Pack Foundation for
Medical Research
Mr. & Mrs. Bernard G. Palitz
The Papamarkou Foundation
Park Avenue Charitable Fund
Mr. Russell P. Pennoyer
The Perkin Fund
The Honorable & Mrs. Carl
H. Pforzheimer, Jr.
Ms. Beatrice Philippe
The Howard Phipps Foundation
Mr. John H. Pinto
Anne & George Popkin Foundation Inc.
Dr. Frank Press
Mr. Andrew W. Regan
Gustave A. Reh, Jr. Unitrust
Harold and Beatrice
Renfield Foundation, Inc.
Mrs. Oscar de la Renta
Estate of Joseph W. Rintelen
Mr. & Mrs. David Rockefeller
Mr. Mark F. Rockefeller
Dr. Richard G. Rockefeller &
Ms. Nancy Anderson
Mr. & Mrs. Theodore C. Rogers
Frederick P. and Sandra P.
Rose Foundation
Mrs. Doris L. Rosenberg
Mr. John M. Rudey
Mr. Oscar M. Ruebhausen
Mr. Richard E. Salomon
The Richard and Edna Salomon
Foundation, Inc.
Mr. Sanford J. Schlesinger
Mr. Sidney H. Schneck
Estate of Elise M. Schuppe
The Edith M. Schweckendieck
Charitable Trust
Mr. Charles Scribner, Jr.
Dr. & Mrs. Frederick Seitz
Mr. & Mrs. Jerome A. Siegel
Herbert and Nell Singer
Foundation, Inc.
The Skin Disease Society, Inc.
Alfred P. Sloan Foundation
Seth Sprague Educational &
Charitable Foundation
Mr. Stephen Stamas
Estate of Robert Stevens
Mr. Robert G. Stone
Mr. Frederick A. Terry, Jr.
Dr. P. Roy Vagelos
Mr. John H. Vogel
Watcha Fund
The Sidney J. Weinberg, Jr. Foundation
The Isak & Rose Weinman
Foundation, Inc.
Nina W. Werblow Charitable Trust
Mr. Edwin C. Whitehead
The Whitehead Foundation

Mr. Julius Wile
Mr. Allan Wittman
Ms. Diane Wolf
Adm. Elmo R. Zumwalt

Corporations
and Corporate
Foundations
Alimansky Capital Group Inc.
Bristol-Myers Squibb Company
Bristol-Myers Squibb Foundation. Inc.
Carnegie Council on Ethics/lnt'I Affairs
Celgene Corporation
Chanel, Inc.
Charmer Industries, Inc.
Consolidated Edison Company
of New York
E. I. du Pont de Nemours & Company
Hoffmann-LaRoche Inc.
The IFF Foundation Inc.
Industrias Villares, S.A.
ITT Corporation
Merck & Co., Inc.
Pfizer Foundation, Inc.
The Rockefeller Group
Charles Sadek Import Co., Inc.
Spaulding & Evenflo Companies, Inc.
Volvo
The Whitney Group
The Wilkerson Group, Inc.

Payments Received
during FY92 on pledges
made in previous years
Mr. Ralph E. Ablon
The Annenberg Foundation
ARCS Foundation. Inc.
Rose M. Badgeley Residuary
Charitable Trust
The Becton Dickinson Foundation
Mr. Curtis L. Blake
Botwinick-Wolfensohn Foundation, Inc.
Bristol-Myers Squibb Company
The Brookdale Foundation
Dr. Ronald E. Cape
The Commonwealth Fund
Mr. Disque D. Deane
Ira W. DeCamp Foundation
Elf Aquitaine. Inc.
Francis Florio Fund of
The New York Community Trust
Mr. Richard M. Furlaud
Ms. Neva R. Goodwin
Mrs. Eileen R. Growald
Mary W. Harriman Foundation
Ms. Maxine Harrison
Lita Annenberg Hazen Charitable Trust
Mrs. Marian S. Heiskell
The Carl J. Herzog Foundation, Inc.
Mr. William R. Hewlett
The Irma T. Hirschi Trust

Hoechst Celanese Corporation
Suzanne T. Karpas & Irving D. Karpas,
Jr. Foundation, Inc.
Eugene M. Lang Foundation
Dorothea Leonhardt Fund of
Communities Foundation of Texas
Richard Lounsbery Foundation
Mr. John D. Macomber
Edward Mallinckrodt, Jr. Foundation
Lucille P. Markey Charitable Trust
William & Helen Mazer Foundation
The Merck Company Foundation
Ogden Management Services, Inc.
The Pew Charitable Trusts
The Carl and Lily
Pforzheimer Foundation
Charles H. Revson Foundation
Mr. David Rockefeller, Jr.
Dr. Richard G. Rockefeller
Dr. George Rosenkranz
Lawrence Ruben 198J Charitable Trust
The Richard and Edna Salomon
Foundation. Inc.
Mr. Morris M. Schrier
Mr. R. L. Van Valer
Mr. John C. Whitehead
The Norman and Rosita
Winston Foundation, Inc.

Gifts to Endowment
Mr. Ralph E. Ablon
Stanley Abrams Memorial Fund
Allen & Company
The Diana L. and Arthur G.
Altschul Fund
The Annenberg Foundation
Anonymous
The Leslie Arps Cancer Fund
The Vincent Astor Foundation
Arnold and Mabel Beckman Foundation
Alumnae Association of the
Bellevue School of Nursing
Mr. David Blech
Gladys Brooks Foundation
Estate of Beatrice Bruyn
Cancer Research Institute
Chevron U.S.A. Inc.
Dr. & Mrs. Purnell W. Choppin
Mrs. Irma L. Croll
The Irma and Abram Croll
Foundation. Inc.
Dr. Bernard S. Davison
Mr. & Mrs. J. Richardson Dilworth
The Camille and Henry Dreyfus
Foundation, Inc.
Ors. Julian & Elizabeth Eisenstein
The Charles Engelhard Foundation
Sherman Fairchild Foundation, Inc.
Dr. Jack Fishman
Mrs. Rita R. Fraad
Estate of Ernst Friedheim
Dr. Eugene Garfield
Mr. Clar�nce H. Gifford, Jr.
Estate of Henry A. Gilbert
Gulf Oil Foundation
Mr. & Mrs. Patrick E. Haggerty
Ms. Maxine Harrison

The Carl J. Herzog Foundation, Inc.
Mr. Leon Hess
Hess Foundation, Inc.
Hormone Research Foundation
IBM Corporation
Sumi L. Koide Memorial Fund
Lakeview Fund, Inc.
The Leonhardt Foundation, Inc.
The Dorothea L. Leonhardt
Foundation, Inc.
Dorothea Leonhardt Fund of
Communities Foundation of Texas
Frederick H. Leonhardt Fund of
The New York Community Trust
Marjorie Lewisohn
Dolores Z. Liebmann Trust
Burton A. Maddock Trust
Lucille P. Markey Charitable Trust
Estate of Abby R. Mauze
The Andrew W. Mellon Foundation
Richard King Mellon Foundation
The Merck Company Foundation
The Andre and Bella Meyer
Foundation, Inc.
Estate of Stanford Moore
Mr. Gunnar W. E. Nicholson
Ogden Management Services, Inc.
Mr. & Mrs. George D. O'Neill
The Rapid-American Foundation for the
Benefit of The Rockefeller University
Harold and Beatrice Renfield
Foundation, Inc.
R. J. Reynolds Industries, Inc.
Mr. David Rockefeller
Rockefeller Brothers Fund
Mr. Frederick P. Rose
Mr. Jack Rudin
Raymond and Beverly Sackler
Foundation, Inc.
Mr. Morris M. Schrier
Mr. Gunther K. Schwerin
Spaulding & Evenflo Companies, Inc.
Squibb Corporation
William H. Stein Fund
Surdna Foundation
Toyota Motor Corporation
Estate of John Manning Van Heusen
DeWitt Wallace Fund #3 of
Community Funds, Inc.
Miriam and Ira D. Wallach Foundation
Dr. & Mrs. Jerry A. Weisbach
Estate of James R. Withrow, Jr.
Lester Wolfe Charitable Trust

In-kind Donations
Individuals
Mr. Gunther K. Schwerin

Corporations
Harris Corporation
Zetaco, Inc,
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The Rockefeller
University
Board of Trustees

Mr. Richard M. Furlaud
Chairman (nonexecutive) of the Board
American Express Company
and former Chairman and CEO
Squibb Corporation

Mrs. Vincent Astor, Life Trustee
President
The Vincent Astor Foundation

Dr. William 0. Baker, Chairman Emeritus
Retired Chairman
AT& T/Be/1 Laboratories

Dr. Torsten Wiesel
President
The Rockefeller University

Mr. Robert M. Bass
President
Keystone, Inc.

Or. Alexander G. Bearn
Adjunct Professor
The Rockefeller University

Dr. Ronald C. Breslow
SL. Mitchi/1 Professor
of Chemistry
Columbia University

Mr. Gustavo A. Cisneros

Chairman and Chief
Executive Officer
Organizacion Cisneros

Dr. Edward S. Cooper
Professor of Medicine
University of Pennsylvania

Mr. D. Ronald Daniel
Director
McKinsey & Company, Inc.

Alexander D. Forger, Esq.
Partner
Milbank, Tweed, Hadley
& McCloy

Dr. Neva R. Goodwin
Director, Program for Sustainable
Change and Development
Tuffs University

Mr. Eugene Grisanti

Mr. Richard E. Salomon

Chairman and President
International Flavors
and Fragrances, Inc.

Dr. Pehr G. Gyllenhammar
Executive Chairman
AB VOLVO

Managing Director
Spears, Benzak, Salomon
& Farrell Inc.

Mr. Stephen Stamas
President
New York Philharmonic

Dr. David A. Hamburg

Frederick A. Terry, Jr., Esq.

Mrs. W. Averell Harriman

Ms. Alair Townsend

President
Carnegie Corporation of New York
Washington, DC

Partner
Sullivan & Cromwell
Publisher
Grain's New York Business

Dr. Heisuke Hironaka
William Elwood Byerly
Professor of Mathematics
Harvard University

Mrs. Eugene M. Lang
New York, NY
Dr. Philip Leder

Or. P. Roy Vagelos
Chairman and Chief
Executive Officer
Merck & Co., Inc.

Mr. John C. Whitehead

Chairman, Department
of Genetics
Harvard Medical School

Dr. Evelyn G. tipper
Associate Professor and
Associate Attending Physician
Cornell University
Medical College

Mr. John D. Macomber
Former President and Chairman
Export-Import Bank of the US.

Dr. Ernest Mario

Chairman
AEA Investors, Inc.

Mr. James D. Wolfensohn
President
James D. Wolfensohn, Inc.

Officers of
the University
Dr. Torsten Wiesel
President

Mr. Frederick M. Bohen

Durham, NC

Executive Vice President

Dr. Frank Press
President
National Academy of Sciences

Mr. John S. Reed

Mr. David J. Lyons
Vice President for Business
and Finance; Treasurer

William H. Griesar, Esq.

Chairman
Citicorp

Mrs. Oscar de la Renta
New York, NY

Vice President and
General Counsel

Dr. Zanvil A. Cohn

Vice President for Medical Affairs

Mr. David Rockefeller

Ms. Ingrid W. Reed

New York, NY

Or. Richard G. Rockefeller
Portland, ME

Vice President for Public Affairs
and Secretary of the Corporation

Mr. John J. Harrigan

Mr. Frederick P. Rose
Chairman
Rose Associates, Inc.

Controller and Associate
Treasurer

Ms. Robin Maloney
Associate Controller and
Assistant Treasurer
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Endnotes

Factors Favorable for the·
Continued Advance of Science

by Frederick Seitz

Dr. Frederick Seitz, president emeritus
of The Rockefeller University and for
mer president of the National Academy
of Sciences, considers the future of scien
tific research in the following excerpt
from his new bo ok, The Science

Mat rix: The Journey, Travails,
Triumphs (New York: Springer
Verlag, 1992).

INNATE CURIOSITY
The most important factor assuring
the continued advance of basic sci
ence lies in the combination of
earnest curiosity regarding nature
and the desire for self-expression
that resides in many talented and
imaginative young people-deeply
ingrained human traits. These traits
have been instrumental in the evolu
tion of science from its beginning.
Indeed, such curiosity can continue
unabated for a lifetime in the well
initiated, not least in the profession
al scientist, in spite of varying levels
of creativity.
Alongside this we now possess, as
a result of nearly five centuries of

experience, knowledge of the combi
nation of experiment, logical analy
sis, speculative theory and institu
tional structure needed to form a
solid platform for the advance of sci
ence. None of these guarantee the
appearance of that flash of inspired
insight from a great mind that is
occasionally necessary to introduce a
major new evolutionary concept 1n
some field. In this respect we will
apparently always depend upon the
arrival of the appropr�ate level of
genius at the active scene during
special periods in the development
of a field. Fortunately, such preg
nant moments seem to attract the
appropriately gifted sooner rather
than later. One can only hope that
this will continue to be the case
indefinitely.

PRACTICAL NEED,
NATIONAL PRIDE
Also on the positive side, it seems
clear at present that under normal
circumstances the advanced industri
al societies will have a continuous
need for the further infusion of new
scientific knowledge for several good
reasons. Some of the need will arise
from a basic interest in the revela
tions of science, some from its edu
cational value, and some from issues
such as the improvement of public
health, industrial competitiveness,
defense and what might be called
replacement technology-such as
finding substitutes for materials in
dwindling supply.
Then, too, there is national
pride, which has been a significant
motivating factor in the past and
which will probably be significant as
long as we have a diversity of ethnic
and cultural groups on an interna
tional scale....

GLOBAL ISSUES
Finally, it is likely that there will be
global problems that require the
encouragement of reasonably coor
dinated basic as well as applied
research ;t many centers on a world
wide basis. Issues such as concern
about the global environment or
problems related to health such as
cancer and acquired immune defi
ciency syndrome (AIDS), not to
mention as yet unfo reseen but
inevitable pandemics, will require
enlisting scientists from many insti
tutions who are prepared to work at
the most basic levels of current
understanding. It is, in fact, remark
able that the worldwide epidemic of
AIDS occurs just when our ability to
achieve understanding of the disease
is possible and when detailed scien
tific investigations can be carried out
internationally in a concerted way.
This is undoubtedly not the last
time that the international scientific
community will be called upon in a
similar manner.
Then too, there will be less life
threatening scientific adventures
which can benefit from international
cooperation. The coordinated
research programs in the antarctic
provide one present-day example.
The development of very high reso
lution astronomical observatories on
the moon, including extended arrays
which might observe planets on
neighboring stars, could provide
such an international adventure in
the near future.
Reprinted with permission from Springer-Verlag
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